Newly diagnosed breast cancer is most commonly classified into one of several molecular or intrinsic subtypes according to the status or level of ER and PR sex hormone receptor expression, growth factor receptor HER2, and proliferation marker Ki-67. The gene discussed is ERBB2; the disease is breast carcinoma.